Neuromyelitis optica spectrum disorder in pediatrics. Case report

Introduction: Neuromyelitis optica is an inflammatory disorder of the central nervous system that accounts for 5% of demyelinating diseases in pediatrics. Its clinical presentation is variable and associated to the involved area of the central nervous system. Case presentation: This is the case of...

Full description

Saved in:
Bibliographic Details
Main Authors: Jhon Camacho, Sebastian Zuleta, Maria Paula Alba, Andrea Hernandez, Carlos Navas
Format: Article
Language:English
Published: Universidad Nacional de Colombia 2019-01-01
Series:Case Reports
Subjects:
Online Access:https://revistas.unal.edu.co/index.php/care/article/view/74943
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846152057966297088
author Jhon Camacho
Sebastian Zuleta
Maria Paula Alba
Andrea Hernandez
Carlos Navas
author_facet Jhon Camacho
Sebastian Zuleta
Maria Paula Alba
Andrea Hernandez
Carlos Navas
author_sort Jhon Camacho
collection DOAJ
description Introduction: Neuromyelitis optica is an inflammatory disorder of the central nervous system that accounts for 5% of demyelinating diseases in pediatrics. Its clinical presentation is variable and associated to the involved area of the central nervous system. Case presentation: This is the case of a 15-year-old patient who consulted several times for nonspecific neurological symptoms. During his last visit to the Clínica Universitaria Colombia in Bogotá, he presented with bilateral optic neuritis, associated with frontal and parietal headache. Immunophenotyping studies were carried out, reporting positive IgG anti-aquaporin 4 antibodies (anti-AQP4 antibody), thus leading to a diagnosis of seropositive neuromyelitis optica spectrum disorder (NMOSD). Management with methylprednisolone pulses was initiated with subsequent outpatient management with rituximab that allowed stabilizing the disease. Discussion: This is an interesting case due to its insidious and uncertain onset in a pediatric patient. It was possible to evaluate clinical and diagnostic differences in relation to its presentation in adults. NMOSD mediated by anti-AQP4 is rare; brain and bone marrow MRI are essential for diagnosis. The treatment of choice for acute conditions consists of high doses of methylprednisolone. Conclusion: This disorder may result in irreversible neurological damage; for this reason, high suspicion is required for early diagnosis and timely treatment.
format Article
id doaj-art-7e3f5f712d6c4e58ac1f0a72d61b21c7
institution Kabale University
issn 2462-8522
language English
publishDate 2019-01-01
publisher Universidad Nacional de Colombia
record_format Article
series Case Reports
spelling doaj-art-7e3f5f712d6c4e58ac1f0a72d61b21c72024-11-26T23:59:24ZengUniversidad Nacional de ColombiaCase Reports2462-85222019-01-015110.15446/cr.v5n1.7494350173Neuromyelitis optica spectrum disorder in pediatrics. Case reportJhon Camachohttps://orcid.org/0000-0003-0898-9223Sebastian Zuletahttps://orcid.org/0000-0001-6122-4946Maria Paula Albahttps://orcid.org/0000-0002-9009-7509Andrea Hernandezhttps://orcid.org/0000-0002-7714-0189Carlos Navashttps://orcid.org/0000-0002-0472-3930 Introduction: Neuromyelitis optica is an inflammatory disorder of the central nervous system that accounts for 5% of demyelinating diseases in pediatrics. Its clinical presentation is variable and associated to the involved area of the central nervous system. Case presentation: This is the case of a 15-year-old patient who consulted several times for nonspecific neurological symptoms. During his last visit to the Clínica Universitaria Colombia in Bogotá, he presented with bilateral optic neuritis, associated with frontal and parietal headache. Immunophenotyping studies were carried out, reporting positive IgG anti-aquaporin 4 antibodies (anti-AQP4 antibody), thus leading to a diagnosis of seropositive neuromyelitis optica spectrum disorder (NMOSD). Management with methylprednisolone pulses was initiated with subsequent outpatient management with rituximab that allowed stabilizing the disease. Discussion: This is an interesting case due to its insidious and uncertain onset in a pediatric patient. It was possible to evaluate clinical and diagnostic differences in relation to its presentation in adults. NMOSD mediated by anti-AQP4 is rare; brain and bone marrow MRI are essential for diagnosis. The treatment of choice for acute conditions consists of high doses of methylprednisolone. Conclusion: This disorder may result in irreversible neurological damage; for this reason, high suspicion is required for early diagnosis and timely treatment. https://revistas.unal.edu.co/index.php/care/article/view/74943Neuromyelitis OpticaOptic NeuritisAntibodiesAquaporin 4MethylprednisoloneRituximab.
spellingShingle Jhon Camacho
Sebastian Zuleta
Maria Paula Alba
Andrea Hernandez
Carlos Navas
Neuromyelitis optica spectrum disorder in pediatrics. Case report
Case Reports
Neuromyelitis Optica
Optic Neuritis
Antibodies
Aquaporin 4
Methylprednisolone
Rituximab.
title Neuromyelitis optica spectrum disorder in pediatrics. Case report
title_full Neuromyelitis optica spectrum disorder in pediatrics. Case report
title_fullStr Neuromyelitis optica spectrum disorder in pediatrics. Case report
title_full_unstemmed Neuromyelitis optica spectrum disorder in pediatrics. Case report
title_short Neuromyelitis optica spectrum disorder in pediatrics. Case report
title_sort neuromyelitis optica spectrum disorder in pediatrics case report
topic Neuromyelitis Optica
Optic Neuritis
Antibodies
Aquaporin 4
Methylprednisolone
Rituximab.
url https://revistas.unal.edu.co/index.php/care/article/view/74943
work_keys_str_mv AT jhoncamacho neuromyelitisopticaspectrumdisorderinpediatricscasereport
AT sebastianzuleta neuromyelitisopticaspectrumdisorderinpediatricscasereport
AT mariapaulaalba neuromyelitisopticaspectrumdisorderinpediatricscasereport
AT andreahernandez neuromyelitisopticaspectrumdisorderinpediatricscasereport
AT carlosnavas neuromyelitisopticaspectrumdisorderinpediatricscasereport